Find a Trial

Trial Summary


Protocol No.PHO-COG-ANBL1531
StatusOPEN TO ACCRUAL
Principal InvestigatorBatra, Sandeep
ScopeNational
PhasePhase III
Age GroupAdults and Children
TitleA Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)
Applicable Disease SitesSoft Tissue
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactMelissa Lee, Phone: +1 317-944-4281
    Pager: 312-1228
    Email: mellee@iu.edu